Published in Surgery Litigation and Law Weekly, February 9th, 2007
This trend article about Erasmus Medical Center, Rotterdam, Netherlands, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "Surfactant as a carrier: influence of immunosuppressive agents on surfactant activity," have been published. "It has been proposed that exogenous pulmonary surfactant can be used as a drug delivery system for immunosuppressive agents to the alveolar compartment of the lung while reducing the risk of systemic toxicity. Before using this combination, however, alterations in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly